Saturday 17 October 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024. In the quarter to June 2026, revenue grew 17.3%, EPS grew 16.2%, free cash flow grew 12.2% and total debt fell 2.77%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five.
176.63
1.48
−0.83%
Follow ENSG
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 16.46 | 15.44 | 20.27 | 34.89 | 24.06 | 68.29 | 70.29 | 85.50 | 110.71 | 118.73 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 22.32 | 23.18 | 45.80 | 58.93 | 77.27 | 98.66 | 97.42 | 115.11 | 158.45 | 194.00 | |||||
| People | |||||||||||||||
| People | Employees | 19,482 | 21,301 | 23,463 | 24,500 | 24,400 | 25,900 | 29,900 | 35,300 | 39,300 | 46,000 | ||||
| Revenue/emp, $m | 0.08 | 0.08 | 0.07 | 0.08 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | 0.11 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 1,655 | 1,598 | 1,755 | 2,037 | 2,403 | 2,627 | 3,025 | 3,729 | 4,260 | 5,058 | ||||
| Gross margin, % | 11.39 | 10.82 | 12.46 | 14.29 | 16.96 | 17.82 | 17.12 | 15.84 | 15.67 | 15.81 | |||||
| EBT | 86 | 31 | 72 | 116 | 218 | 258 | 289 | 273 | 386 | 456 | |||||
| EBT margin, % | 5.19 | 1.95 | 4.09 | 5.70 | 9.06 | 9.82 | 9.56 | 7.31 | 9.06 | 9.01 | |||||
| Net income | 53 | 41 | 93 | 112 | 171 | 198 | 225 | 210 | 298 | 344 | |||||
| Depreciation | 40 | 43 | 45 | 52 | 55 | 57 | 63 | 73 | 85 | 105 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 32.73 | 31.38 | 33.73 | 38.10 | 44.96 | 48.22 | 55.12 | 66.94 | 75.20 | 88.26 | ||||
| Earnings | 0.99 | 0.79 | 1.78 | 2.07 | 3.19 | 3.57 | 4.09 | 3.76 | 5.26 | 6.00 | |||||
| Cash flow | 1.46 | 1.56 | 4.04 | 3.60 | 6.99 | 5.06 | 4.97 | 6.76 | 6.13 | 9.85 | |||||
| Capex | (0.49) | (1.01) | (0.89) | (1.20) | (0.93) | (1.24) | (1.44) | (1.91) | (2.79) | (3.38) | |||||
| Free cash flow | 0.98 | 0.55 | 3.16 | 2.40 | 6.05 | 3.82 | 3.53 | 4.86 | 3.34 | 6.47 | |||||
| Book value | 9.11 | 9.82 | 11.58 | 12.28 | 15.31 | 18.75 | 22.75 | 26.88 | 32.48 | 39.00 | |||||
| Shares, m | 51 | 51 | 52 | 53 | 53 | 54 | 55 | 56 | 57 | 57 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 21.15 | 27.26 | 20.50 | 21.92 | 22.86 | 23.45 | 23.11 | 30.49 | 25.26 | 28.99 | ||||
| P/S | 0.64 | 0.70 | 1.08 | 1.19 | 1.62 | 1.74 | 1.71 | 1.71 | 1.77 | 1.97 | |||||
| P/B | 2.30 | 2.22 | 3.13 | 3.70 | 4.76 | 4.48 | 4.15 | 4.27 | 4.09 | 4.47 | |||||
| EV/Sales | 0.77 | 0.86 | 1.19 | 1.31 | 1.57 | 1.70 | 1.66 | 1.61 | 1.68 | 1.89 | |||||
| EV/FCF | 25.81 | 48.68 | 12.74 | 20.89 | 11.63 | 21.42 | 25.87 | 22.22 | 37.82 | 25.77 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 74 | 80 | 210 | 192 | 373 | 276 | 273 | 377 | 347 | 564 | ||||
| Capex | (25) | (51) | (46) | (64) | (50) | (68) | (79) | (106) | (158) | (194) | |||||
| Free cash flow | 49 | 28 | 164 | 128 | 323 | 208 | 194 | 270 | 189 | 371 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 122 | 142 | 79 | 68 | 21 | 117 | 199 | 312 | 414 | 378 | ||||
| Total debt | 284 | 313 | 243 | 328 | 116 | 157 | 153 | 149 | 146 | 142 | |||||
| Net debt | 214 | 258 | 204 | 251 | (135) | (119) | (179) | (377) | (381) | (431) | |||||
| Shareholders’ equity | 460 | 500 | 602 | 656 | 818 | 1,022 | 1,249 | 1,497 | 1,840 | 2,235 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 5.72 | 3.85 | 8.09 | 6.24 | 6.95 | 7.21 | 7.13 | 5.49 | 6.74 | 6.79 | ||||
| ROIC | 8.51 | 3.56 | 6.59 | 8.90 | 20.40 | 18.04 | 17.33 | 14.25 | 15.35 | 14.73 | |||||
| ROE | 11.27 | 8.43 | 16.76 | 17.57 | 23.13 | 21.16 | 19.79 | 15.25 | 17.85 | 16.88 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
The Ensign Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare Corporation | $22.2B | 10.3× | 6.4× | +14.61% (above 0%: growing) | +212.97% (above 0%: growing) | −43.88% (below 0%: shrinking) | 46.78% | 24.85% | Compare |
| EHC Encompass Health Corporation | $12.6B | 20.6× | 16.8× | +9.58% (above 0%: growing) | +9.93% (above 0%: growing) | −45.01% (below 0%: shrinking) | 100.00% | 17.85% | Compare |
| DVA DaVita Inc. | $12.1B | 15.0× | 13.1× | +5.17% (above 0%: growing) | +56.49% (above 0%: growing) | +49.36% (above 0%: growing) | 32.70% | 16.29% | Compare |
| FMS Fresenius Medical Care AG & Co. KGaA | $11.8B | 11.5× | 12.5× | +3.89% (above 0%: growing) | +6.82% (above 0%: growing) | +1.57% (above 0%: growing) | 26.95% | 9.58% | Compare |
| UHS Universal Health Services, Inc. | $11.0B | 7.5× | 6.1× | +8.27% (above 0%: growing) | +9.47% (above 0%: growing) | −23.78% (below 0%: shrinking) | 90.87% | 11.14% | Compare |
| ENSG The Ensign Group, Inc. | $10.4B | 26.9× | 24.1× | +17.33% (above 0%: growing) | +16.22% (above 0%: growing) | +12.24% (above 0%: growing) | 16.65% | 8.50% | |
| PACS PACS Group, Inc. | $7.6B | 27.6× | 16.8× | +9.07% (above 0%: growing) | +45.45% (above 0%: growing) | +220.51% (above 0%: growing) | 17.07% | 7.66% | Compare |
| CHE Chemed Corporation | $6.7B | 25.7× | 20.4× | +8.80% (above 0%: growing) | +42.78% (above 0%: growing) | −43.51% (below 0%: shrinking) | 32.90% | 13.25% | Compare |
| CON Concentra Group Holdings Parent, Inc. | $5.0B | 24.9× | 17.0× | +10.03% (above 0%: growing) | +45.71% (above 0%: growing) | +91.62% (above 0%: growing) | 31.70% | 18.99% | Compare |
| Median of peers | $11.4B | 17.8× | 15.0× | +8.94% | +44.12% | −11.11% | 32.80% | 14.77% |
The Ensign Group, Inc. (ENSG) key facts
- Strength: The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Strength: Net income was $344.3 million, or $6.00 per share (basic), a net margin of 6.80%.
- The Ensign Group, Inc. (ENSG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, ENSG traded at $176.63, a market capitalization of $10.4 billion.
- At that price the stock trades at 26.9× trailing-twelve-month earnings and 1.9× sales; its P/E is higher than 73% of its own readings over the past ten years.
- The Ensign Group, Inc. pays an annual dividend of $0.26 per share, a yield of 0.15%, with a payout ratio of 4.08%.
- Return on equity was 16.9% and debt-to-equity 0.06.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.57 (safe zone) for fiscal 2025.